Organicell Regenerative Medicine (OTCMKTS:BPSR) Share Price Crosses Below Fifty Day Moving Average – Time to Sell?

Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.33 and traded as low as $1.85. Organicell Regenerative Medicine shares last traded at $1.96, with a volume of 762 shares traded.

Organicell Regenerative Medicine Price Performance

The business’s 50-day simple moving average is $2.33 and its 200-day simple moving average is $2.08.

About Organicell Regenerative Medicine

Organicell Regenerative Medicine, Inc is a clinical‐stage biotechnology company dedicated to the development and commercialization of cell and exosome‐based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal‐like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.

The company’s pipeline is anchored by exosome‐centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.